文献速递脊柱关节炎

银屑病关节炎诊断前后社会成本与健康不公平:丹麦队列研究

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.
PubMed 文献 · Ann Rheum Dis · 2017-01-30

该研究基于丹麦全国注册数据,纳入10 525例银屑病关节炎(PsA)患者和20 777名匹配的普通人群对照,比较诊断前后的共病、医疗与公共转移支付成本及就业状况。结果显示PsA患者共病更多、总医疗与公共转移支付成本更高、收入更低,诊断后每患者年净平均社会成本增加€10 641;残疾养老金相对风险从诊断前5年的1.36升至诊断时的1.60和诊断后10年的2.69。

要点

  • PsA患者基线共病显著多于对照,包括心血管病、呼吸系统疾病和感染性疾病。
  • 诊断后每患者年净平均社会成本较对照增加€10 641,各时间点医疗与公共转移支付成本均更高。
  • 残疾养老金相对风险随诊断前后时间推移升高,诊断后10年达2.69。

核心结论

  • 研究结果提示PsA患者存在健康不公平,呼吁个体化预防措施和社会行动。

研究设计与样本

  • 比较PsA患者诊断前后与普通人群对照的共病、社会成本、就业状况和公共转移支付成本。

主要发现

  • 基线时PsA患者心血管病OR 1.70(95%CI 1.55至1.86)、呼吸系统疾病OR 1.73(95%CI 1.54至1.96)、感染性疾病OR 2.03(95%CI 1.69至2.42),均显著高于对照。
  • 所有时间点PsA患者总医疗和公共转移支付成本均更高,收入更低(p<0.001)。
  • 诊断后每患者年净平均社会成本较对照增加€10 641。
  • 诊断前5年残疾养老金RR 1.36(95%CI 1.24至1.49),诊断时RR 1.60(95%CI 1.49至1.72),诊断后10年RR 2.69(95%CI 2.40至3.02),此时21.8%的PsA患者领取残疾养老金。

临床怎么用

  • 风湿免疫科医生应关注PsA患者诊断前后的共病筛查与社会经济负担,及早识别残疾养老金风险升高者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To comprehensively study the comorbidities, healthcare and public transfer (allowance) costs in patients with psoriatic arthritis (PsA) before and after diagnosis. METHODS: Nationwide cohort study, using data from Danish registries from January 1998 through December 2014. A total of 10 525 patients with PsA and 20 777 matched general population comparator (GPC) subjects were included. Societal costs, employment status and occurrence of comorbidities in patients with PsA both before and after diagnosis were compared with GPC subjects. RESULTS: At baseline, patients with PsA had significantly more comorbidities, including cardiovascular disease (OR 1.70 95% CI 1.55 to 1.86), respiratory diseases (OR 1.73 95% CI 1.54 to 1.96) and infectious diseases (OR 2.03 95% CI 1.69 to 2.42) compared with GPC subjects. At all time points, patients with PsA had higher total healthcare and public transfer costs; they also had lower income (p<0.001) and incurred a net average increased societal cost of €10 641 per patient-year compared with GPC subjects following diagnosis. The relative risk (RR) for being on disability pension 5 years prior to PsA diagnosis was 1.36 (95% CI 1.24 to 1.49) compared with GPC subjects. The RR increased to 1.60 (95% CI 1.49 to 1.72) at the time of diagnosis and was 2.69 (95% CI 2.40 to 3.02) 10 years after diagnosis, where 21.8% of the patients with PsA received disability pension. CONCLUSIONS: Our findings are suggestive of health inequity for patients with PsA and call for individual preventive measures and societal action.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kristensen LE, Jørgensen TS, Christensen R, et al. Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study. Ann Rheum Dis. 2017. PMID: 28137915. doi:10.1136/annrheumdis-2016-210579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。